Meeting
2014 ASCO Annual Meeting
Evaluation of the prostate health index (PHI) as a novel biomarker in active surveillance of prostate cancer.
Authors
Andrew Eichholz
University College London Hospitals NHS Foundation Trust, London, United Kingdom
Andrew Eichholz , Frank McCarthy , Nening Dennis , Karen Thomas , Tim Howlett , Jhangir Iqbal , Jan Amin , Mildred Tan , Mausam Singhera , Elizabeth Selvadurai , Robert Anthony Huddart , David Paul Dearnaley , Chris Parker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 5071)
DOI
10.1200/jco.2014.32.15_suppl.5071
Abstract #
5071
Poster Bd #
200
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS).
First Author: Anna Lantz
Poster
2017 Genitourinary Cancers Symposium
Comparison of multiparametric MRI to PSA kinetics as an indication of prostate cancer progression in men on active surveillance.
First Author: Mahir Maruf
Poster
2014 ASCO Annual Meeting
Role of serum lipids and glucose as biomarkers of prostate cancer severity.
First Author: Alejo Rodriguez-Vida
Poster
2014 Genitourinary Cancers Symposium
Evaluation of the prostate health index (phi) as a novel biomarker in active surveillance of prostate cancer.
First Author: Andrew Eichholz